SEC Form 3 · accession 0001663577-17-000208
Blake Insomnia Therapeutics, Inc. · BKIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birger Jan Olsen
Officer — CEO · Director · 10% Owner
Period of report
Dec 23, 2014
Accepted (ET)
Jul 13, 2017 · 12:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.